ROXRO PHARMA INC has a total of 32 patent applications. Its first patent ever was published in 2005. It filed its patents most often in China, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals and medical technology are BODOR NICHOLAS, HOPE MEDICAL ENTPR INC DBA HOPE PHARMACEUTICALS and INTERMUNE.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Republic of Korea | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Argentina | 2 | |
#6 | Australia | 2 | |
#7 | Canada | 2 | |
#8 | Taiwan | 2 | |
#9 | United States | 2 | |
#10 | South Africa | 2 | |
#11 | Brazil | 1 | |
#12 | Costa Rica | 1 | |
#13 | Israel | 1 | |
#14 | Japan | 1 | |
#15 | Mexico | 1 | |
#16 | Norway | 1 | |
#17 | New Zealand | 1 | |
#18 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Medical purpose containers | |
#4 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Whiting Roger | 24 |
#2 | Thirucote Ramachandran | 24 |
#3 | Ramachandran Thirucote | 6 |
#4 | Roger Whiting | 6 |
Publication | Filing date | Title |
---|---|---|
TW201043277A | Device for intranasal administration | |
AU2009257385A1 | Pharmaceutical formulation of ketorolac for intranasal administration | |
AU2005322305A1 | Therapeutic compositions for intranasal administration of ketorolac |